BRAFV600E targeted therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BRAFV600E targeted therapy, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients